Trial Profile
Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients With Advanced Colorectal or Gastric Cancer Treated With FOLFIRI Regimen
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid
- Indications Colorectal cancer; Gastric cancer
- Focus Adverse reactions; Pharmacogenomic
- 27 Jan 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 09 Jan 2018 Planned End Date changed from 1 Jul 2016 to 1 Dec 2018.
- 12 Jan 2016 Planned End Date changed from 1 Jul 2015 to 1 Jul 2016 as reported by ClinicalTrials.gov record.